Tiger Brokers

iX Biopharma issues 29,750 new shares after warrant exercise

SGX Filings
May 22

iX Biopharma Ltd. announced on May, 22 2026 that it has allotted and issued 29,750 new ordinary shares pursuant to the exercise of warrants priced at 0.06 Singapore dollars each.

The issuance increases the company’s total outstanding shares to 1,056,936,965 from 1,056,907,215. The new shares will rank pari passu with existing shares and are expected to begin trading on the Singapore Exchange on May, 26 2026.

Following this transaction, 20,759,901 warrants—representing 36.10% of all warrants originally issued—have been exercised. A total of 36,749,578 warrants remain outstanding, each carrying an exercise price of 0.06 Singapore dollars and expiring on Jul, 18 2026.

Warrant holders can find detailed exercise instructions at the company’s website.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10